Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement

Journal of Cardiac Surgery

Volumn 20, Issue 2, 2005, Pages 171-176

  Fattouch, Khalil ^a,c   Sbraga, Fabrizio ^a   Bianco, Giuseppe ^a   Speziale, Giuseppe ^b   Gucciardo, Marco ^a   Sampognaro, Roberto ^a   Ruvolo, Giovanni ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b Cardiac Surgery Center   (Italy)

^c NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; NITROPRUSSIDE SODIUM; PROSTACYCLIN;

ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HEART OUTPUT; HEART RIGHT VENTRICLE FAILURE; HEART SURGERY; HEMODYNAMICS; HUMAN; HYPOTENSION; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; METHEMOGLOBINEMIA; MITRAL VALVE REPLACEMENT; MITRAL VALVE STENOSIS; PHARMACODYNAMICS; POSTOPERATIVE COMPLICATION; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, INHALATION; ANTIHYPERTENSIVE AGENTS; CARDIOPULMONARY BYPASS; DOUBLE-BLIND METHOD; ENDOTHELIUM-DEPENDENT RELAXING FACTORS; EPOPROSTENOL; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; MITRAL VALVE; MITRAL VALVE STENOSIS; NITRIC OXIDE; NITROPRUSSIDE;

EID: 16244399842     PISSN: 08860440     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0886-0440.2005.200383w.x     Document Type: Article

References (26)

1. Lesage AM, Tsuchoika H, Young WG Jr, et al: Pathogenesis of pulmonary damage during extracorporeal perfusion. Arch Surg 1996;93:1002-1008.
2. Costard-Jackle A, Fowler MB: Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: Testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. J Am Coll Cardiol 1992;19:48-54.
3. Speziale G, De Biase L, De Vincentis G, et al: Inhaled nitric oxide in patients with severe heart failure: Changes in lung perfusion and ventilation detected using scintigraphy. Thorac Cardiovasc Surg 1996;44:35-39.
4. Kirklin JK, Naftel DC, McGiffin DC, et al: Analysis of morbid events and risk factors for death after cardiac transplantation. J Am Coll Cardiol 1998;11:917-921.
5. Polak J, Holman L, Wynne J, et al: Right ventricular ejection fraction: An indicator of increased mortality in patients with congestive heart failure associated with coronary artery disease. J Am Coll Cardiol 1983;2:217.
6. Downing SW, Edminds H: Release of vasoactive substances during cardiopulmonary bypass. Ann Thorac Surg 1992;54:1236-1243.
7. Ruvolo G, Speziale G, Greco E, et al: Nitric oxide release during hypothermic vs normothermic cardiopulmonary bypass. Eur J Cardiothorac Surg 1995;9:651-654.
8. Speziale G, Ruvolo G, Marino B: A role for nitric oxide in the vasoplegic syndrome. J Cardiovas Surg 1996;37:301-303.
9. Ruvolo G, Greco E, Speziale G, et al: Nitric oxide formation during cardiopulmonary bypass. Ann Thorac Surg 1994;57:1055-1057.
10. Rubin JL, Gorves BM, et al: Prostacyclin-induced acute pulmonary vasodilatation in primary pulmonary hypertension. Circulation 1982;66:334-338.
11. Ferreira SH, Vane JR: Prostaglandins: Their disappearance from and release into the circulation. Nature 1967;216:868-873.
12. Girard C, Lehot J-J, Pannetier J-C, et al: Inhaled nitric oxide after mitral valve replacement in patients with chronic pulmonary artery hypertension. Anesthesiology 1992;77:880-883.
13. Haraldsson A, Kieler-Jensen N, Nathorst Westfelt U, et al: Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance. Chest 1998;114:780-786.
14. Loscalzo J: Endothelial dysfunction in pulmonary hypertension. N Engl J Med 1992;327:117-119.
15. Palmer R, Ferrige A, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxion factor. Nature 1987;327:524-526.
16. Speziale G, Stazi G: Changes in nitric oxide release in normotensive patients: A pattern of youth predisposing to hypertension in later years? Int J Cardiovasc Dis 2000;17:17-20.
17. Szczeklik A, Szczeklik J, Nizenkowski R: Prostacyclin for pulmonary hypertension. Lancet 1980;2:1076.
18. Rubin LJ, Mendoza J, Hood M, et al: Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (esoprostenol): Results of a randomised trial. Am Intern Med 1990;112:485-491.
19. Kieler-Jensen N, Milocco I, Ricksten SE: Pulmonary vasodilatation after heart transplantation. A comparison among prostacyclin, sodio nitroprusside, and nitroglycerin on right ventricular function and pulmonary selectivity. J Heart lung Trasplant 1993;12:179-184.
20. Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, et al: Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 1991;338:1173-1174.
21. Jones DK, Higenbottam T, Wallwork J: Treatment of primary pulmonary hypertension with intravenous epoprostenol (prostacyclin). Br Heart J 1987;57:270-278.
22. Schranz D, Zepp F, Iversen S, et al: Effects of tolazoline and prostacyclin on pulmonary hypertension in infants after cardiac surgery. Crit Care Med 1992;20:1243-1249.
23. Frostell C, Fratacci MD, Wain JC, et al: Inhaled nitric oxide: A selective pulmonary vasodilatator reversing hypoxic pulmonary vasoconstriction. Circulation 1991;83:2038-2047.
24. Armitage JM, Hardesty RL, Griffith BP: Prostaglandin E1: An effective treatment of right heart failure after orthotopic heart transplantation. J Heart Transplant 1987;6:348-351.
25. Faymonville ME, Deby-Dupont G, Larbuisson R, et al: Prostaglandin E2, prostacyclin, and thrombaxane changes during non-pulsatile cardiopulmonary bypass in humans. J Thorac Cardiovasc Surg 1986;91:858-866.
26. Wessel DL, Ian Adatia, Giglia TM, et al: Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation 1993;88:2128-2138.